RSS-Feed abonnieren
DOI: 10.1055/s-0040-1706299
Convergent Synthesis of Immune Inhibitor IMMH002
This work was financially supported by the National Key R & D Program of China (No. 2018YFC1706403), Drug Innovation Major Project (No. 2018ZX09711001-005.China), CAMS Collaborative Innovation Project (No. 2019-I2M-1-005, China), and Disciplines Construction Project (No. 201920200802, China).
Abstract
A convergent synthesis of IMMH002 in 36% overall yield starting from bromobenzene is described with a key Suzuki–Miyaura cross-coupling reaction used to provide a crucial intermediate. The route does not require column chromatography and solves the most intractable quality problem caused by a homologue by-product in the original linear synthesis. Furthermore, reducing the use of Lewis acid mediated reactions improves the environmental impact of the synthesis and reduces overall waste. The new route described herein is more efficient, convenient, reliable, and economically more viable when compared to the previously reported linear route.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0040-1706299.
- Supporting Information
Publikationsverlauf
Eingereicht: 29. Juli 2020
Angenommen nach Revision: 25. August 2020
Artikel online veröffentlicht:
14. Oktober 2020
© 2020. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Sugahara K, Maeda Y, Shimano K, Mogami A, Kataoka H, Ogawa K, Hikida K, Kumagai H, Asayama M, Yamamoto T, Harada T, Ni P, Inoue S, Kawaguchi A. Br. J. Pharmacol. 2017; 174: 15
- 2a Brinkmann V, Allende ML, Proia RL, Cyster JG. Nature 2004; 427: 355
- 2b Takahashi H, Riether D, Bartolozzi A, Bosanac T, Berger V, Binetti R, Broadwater J, Chen Z, Crux R, Lombaert SD, Dave R, Dines JA, Khan TF, Flegg A, Garrigou M, Hao MH, Huber J, Hutzler JM, Kerr S, Kotey A, Liu W, Lo HY, Loke PL, Mahaney PE, Morwick TM, Napier S, Olague A, Pack E, Padyana AK, Thomson DS, Tye H, Wu L, Zindell RM, Abeywardane A, Simpson T. Eur. J. Med. Chem. 2015; 58: 1669
- 2c Spiegel S, Milstien S. Nat. Rev. Mol. Cell. Biol. 2003; 4: 397
- 2d Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, Hait NC, Allegood JC, Price MM, Avni D, Takabe K, Kordula T, Milstien S, Spiegel S. Cancer Cell 2013; 23: 107
- 3 Peterson LK, Fujinami RS. J. Neuroimmunol. 2007; 184: 37
- 4a Xiao Q, Jin J, Wang X, Hu J, Xi M, Tian Y, Yin D. Bioorg. Med. Chem. 2016; 24: 2273
- 4b Jin J, Xue N, Liu Y, Fu R, Wang M, Ji M, Lai F, Hu J, Wang X, Zhang X, Yin D, Bai L, Chen X. Acta Pharm. Sin. B. 2020; 10: 276
- 5 Xiao Q, Lin C, Wang X, Yin D. Chin. J. Med. Chem. 2016; 4: 307
- 6 Tian Y, Jin J, Wang X, Han W, Li G, Zhou W, Xiao Q, Qi J, Chen X, Yin D. MedChemComm 2013; 4: 1267
- 7 Wang T, Bemis G, Hanzelka B, Zuccola H, Wynn M, Moody CS, Green J, Locher C, Liu A, Gao H, Xu Y, Wang S, Wang J, Bennani YL, Thomson JA, Müh U. ACS Med. Chem. Lett. 2017; 8: 1224
- 8 Stambuli JP, Kuwano R, Hartwig JF. Angew. Chem. Int. Ed. 2002; 41: 4746
- 9a Polshettiwar V, Decottignies A, Len C, Fihri A. ChemSusChem 2010; 3: 502
- 9b Western EC, Daft JR, Johnson EM, Gannett PM, Shaughnessy KH. J. Org. Chem. 2003; 68: 6767
- 9c Brown WS, D’Ariel DB, Sonnier MQ. Jr, Clark WD, Brown FV, Shaughnessy KH. Synthesis 2008; 1965
- 10 Pei W, Li S, Nie X, Li Y, Pei J, Chen B, Wu J, Ye X. Synthesis 1998; 1298
-
11 CCDC 1993823 contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
- 12 Sheldrick GM. Acta Crystallogr., Sect. A 2015; 71: 3
- 13 Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JA. K, Puschmann H. J. Appl. Crystallogr. 2009; 42: 339
- 14 Sheldrick GM. Acta Crystallogr., Sect. C 2015; 71: 3